Daniela Acerbi
- Lung deposition of the extra fine dry powder fixed combination beclomethasone dipropionate plus formoterol fumarate via the NEXT DPI® in healthy subjects, asthmatic and COPD patientsBy Fabrizia Mariotti, Francesco Sergio, Daniela Acerbi, Thomas Meyer and Christiane HerpichFabrizia Mariotti1Corporate Clinical Development, Chiesi Farmaceutici S.p.A., Parma, ItalyFrancesco Sergio1Corporate Clinical Development, Chiesi Farmaceutici S.p.A., Parma, ItalyDaniela Acerbi1Corporate Clinical Development, Chiesi Farmaceutici S.p.A., Parma, ItalyThomas Meyer2Clinical Unit, Inamed GmbH, Gauting, GermanyChristiane Herpich2Clinical Unit, Inamed GmbH, Gauting, Germany
- Pharmacokinetic bioequivalence of inhaled CHF 1535 50/6 vs. the free combination of beclomethasone and formoterol in asthmatic childrenBy Bo L.K. Chawes, Annalisa Piccinno, Eskil Kreiner-Møller, Nanna L. Skytt, Nasim Samandari, Francesco Sergio, Giorgia Ciurlia, Daniela Acerbi and Hans BisgaardBo L.K. Chawes1Danish Pediatric Asthma Center; Health Sciences, University of Copenhagen, Copenhagen University Hospital, Gentofte, Gentofte, DenmarkAnnalisa Piccinno2Chiesi Farmaceutici, S.p.A, Parma, ItalyEskil Kreiner-Møller1Danish Pediatric Asthma Center; Health Sciences, University of Copenhagen, Copenhagen University Hospital, Gentofte, Gentofte, DenmarkNanna L. Skytt1Danish Pediatric Asthma Center; Health Sciences, University of Copenhagen, Copenhagen University Hospital, Gentofte, Gentofte, DenmarkNasim Samandari1Danish Pediatric Asthma Center; Health Sciences, University of Copenhagen, Copenhagen University Hospital, Gentofte, Gentofte, DenmarkFrancesco Sergio2Chiesi Farmaceutici, S.p.A, Parma, ItalyGiorgia Ciurlia2Chiesi Farmaceutici, S.p.A, Parma, ItalyDaniela Acerbi2Chiesi Farmaceutici, S.p.A, Parma, ItalyHans Bisgaard1Danish Pediatric Asthma Center; Health Sciences, University of Copenhagen, Copenhagen University Hospital, Gentofte, Gentofte, Denmark
- Lung bioavailability of beclometasone dipropionate and formoterol fumarate fixed dose combination administered using a pMDI or a novel DPI: NEXThaler®By Dave Singh, Germano Lucci, Daniela Acerbi, Sergio Francesco, Isabella Montagna, Stefano Vezzoli, Shruti Khurana and Gianluigi PoliDave Singh1Medicinal Evaluation Unit, MEU, Manchester, United KingdomGermano Lucci2Corporate Clinical Development, Chiesi Farmaceutici, Parma, ItalyDaniela Acerbi2Corporate Clinical Development, Chiesi Farmaceutici, Parma, ItalySergio Francesco2Corporate Clinical Development, Chiesi Farmaceutici, Parma, ItalyIsabella Montagna2Corporate Clinical Development, Chiesi Farmaceutici, Parma, ItalyStefano Vezzoli3Statistics, CROS NT, Verona, ItalyShruti Khurana1Medicinal Evaluation Unit, MEU, Manchester, United KingdomGianluigi Poli2Corporate Clinical Development, Chiesi Farmaceutici, Parma, Italy
- Pharmacokinetics of tobramycin nebulizer solution (300mg/4ml) administered by Pari e-Flow rapid vs Pari LC plus nebulizer in patients with cystic fibrosis and Pseudomonas aeruginosa infectionBy Mirco Govoni, Gianluigi Poli, Helen Cicirello, Debora Santoro, Daniela Acerbi and Jozef RuzickaMirco Govoni1Clinical Pharmacology, Chiesi Farmaceutici, Parma, ItalyGianluigi Poli1Clinical Pharmacology, Chiesi Farmaceutici, Parma, ItalyHelen Cicirello3Clinical Corporate Development, Chiesi Pharmaceuticals, Inc, Rockville, MD, United StatesDebora Santoro2Statistics & Data Management, Chiesi Farmaceutici, Parma, ItalyDaniela Acerbi1Clinical Pharmacology, Chiesi Farmaceutici, Parma, ItalyJozef Ruzicka4Dept of Pneumology, Fakultná Nemocnica's Poliklinikou, Bratislava, Slovakia (Slovak Republic)
- No age effect on systemic exposure to beclometasone and formoterol after pressurized metered dose inhalation in paediatric, adolescent and adult asthmaBy Mirco Govoni, Annalisa Piccinno, Germano Lucci, Gianluigi Poli, Daniela Acerbi, Dave Singh, Piotr Kuna, Bo Chawes and Hans BisgaardMirco Govoni1Clinical Pharmacology Dpt, Chiesi Farmaceutici, Parma, ItalyAnnalisa Piccinno1Clinical Pharmacology Dpt, Chiesi Farmaceutici, Parma, ItalyGermano Lucci1Clinical Pharmacology Dpt, Chiesi Farmaceutici, Parma, ItalyGianluigi Poli1Clinical Pharmacology Dpt, Chiesi Farmaceutici, Parma, ItalyDaniela Acerbi1Clinical Pharmacology Dpt, Chiesi Farmaceutici, Parma, ItalyDave Singh2Clinical Pharmacology Dpt, The Medicines Evaluation Unit, Manchester, United KingdomPiotr Kuna3Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Lodz, PolandBo Chawes4Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, DenmarkHans Bisgaard4Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark
- Dose-proportional lung bioavailability of beclometasone dipropionate and formoterol fumarate across three different dose strenghts of CHF1535 pMDIBy Giorgia Ciurlia, Annalisa Piccinno, Roberta Baronio and Daniela AcerbiGiorgia Ciurlia1Corporate Clinical Development, Chiesi Farmaceutici S.p.A, Parma, ItalyAnnalisa Piccinno1Corporate Clinical Development, Chiesi Farmaceutici S.p.A, Parma, ItalyRoberta Baronio1Corporate Clinical Development, Chiesi Farmaceutici S.p.A, Parma, ItalyDaniela Acerbi1Corporate Clinical Development, Chiesi Farmaceutici S.p.A, Parma, Italy
- Safety, tolerability and pharmacokinetics of a new inhaled once-daily phosphodiesterase (PDE) 4 inhibitor in healthy volunteersBy Oriana Esposito, Fabrizia Mariotti, Daniela Acerbi, Anna Compagnoni and Marie-Anna NandeuilOriana Esposito1Corporate Clinical Development, Chiesi Farmaceutici SpA, Parma, ItalyFabrizia Mariotti1Corporate Clinical Development, Chiesi Farmaceutici SpA, Parma, ItalyDaniela Acerbi1Corporate Clinical Development, Chiesi Farmaceutici SpA, Parma, ItalyAnna Compagnoni1Corporate Clinical Development, Chiesi Farmaceutici SpA, Parma, ItalyMarie-Anna Nandeuil1Corporate Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy
- Pharmacokinetic interaction of glycopyrronium bromide pMDI and formoterol pMDI: A randomized, open-label, single-dose, 4-way cross-over studyBy Fabrizia Mariotti, Sara Collarini, Anna Compagnoni, Dario Cuomo, Annamaria Muraro and Daniela AcerbiFabrizia MariottiGlobal Clinical Development, Chiesi Farmaceutici, Parma, ItalySara CollariniGlobal Clinical Development, Chiesi Farmaceutici, Parma, ItalyAnna CompagnoniGlobal Clinical Development, Chiesi Farmaceutici, Parma, ItalyDario CuomoGlobal Clinical Development, Chiesi Farmaceutici, Parma, ItalyAnnamaria MuraroGlobal Clinical Development, Chiesi Farmaceutici, Parma, ItalyDaniela AcerbiGlobal Clinical Development, Chiesi Farmaceutici, Parma, Italy
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.